Schizoaffective Disorder in the DSM-5

Characterization of patients with both psychotic and mood symptoms, either concurrently or at different points during their illness, has always posed a nosological challenge and this is reflected in the poor reliability, low diagnostic stability, and questionable validity of DSM-IV Schizoaffective Disorder. The clinical reality of the frequent co-occurrence of psychosis and Mood Episodes has also resulted in over-utilization of a diagnostic category that was originally intended to only rarely be needed. In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, an effort is made to improve reliability of this condition by providing more specific criteria and the concept of Schizoaffective Disorder shifts from an episode diagnosis in DSM-IV to a life-course of the illness in DSM-5. When psychotic symptoms occur exclusively during a Mood Episode, DSM-5 indicates that the diagnosis is the appropriate Mood Disorder with Psychotic Features, but when such a psychotic condition includes at least a two-week period of psychosis without prominent mood symptoms, the diagnosis may be either Schizoaffective Disorder or Schizophrenia. In the DSM-5, the diagnosis of Schizoaffective Disorder can be made only if full Mood Disorder episodes have been present for the majority of the total active and residual course of illness, from the onset of psychotic symptoms up until the current diagnosis. In earlier DSM versions the boundary between Schizophrenia and Schizoaffective Disorder was only qualitatively defined, leading to poor reliability. This change will provide a clearer separation between Schizophrenia with mood symptoms from Schizoaffective Disorder and will also likely reduce rates of diagnosis of Schizoaffective Disorder while increasing the stability of this diagnosis once made.

[1]  G. Kirov,et al.  Genomewide linkage scan in schizoaffective disorder: significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. , 2005, Archives of general psychiatry.

[2]  J. Schwartz,et al.  Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. , 2000, Archives of general psychiatry.

[3]  H. Möller,et al.  Fifteen‐year follow‐up of ICD‐10 schizoaffective disorders compared with schizophrenia and affective disorders , 2004, Acta psychiatrica Scandinavica.

[4]  M. Maj,et al.  Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. , 2000, Journal of affective disorders.

[5]  R. Hemmingsen,et al.  Schizoaffective disorder – the reliability of its clinical diagnostic use , 2006, Acta psychiatrica Scandinavica.

[6]  E. Kraepelin Die Erscheinungsformen des Irreseins , 1992 .

[7]  M. Maj,et al.  Nosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11. , 2008, Asian journal of psychiatry.

[8]  A. Bertelsen,et al.  Family history of psychiatric illness as a risk factor for schizoaffective disorder: a Danish register-based cohort study. , 2005, Archives of general psychiatry.

[9]  J. Potash Carving Chaos: Genetics and the Classification of Mood and Psychotic Syndromes , 2006, Harvard review of psychiatry.

[10]  Peter McGuffin,et al.  A twin study of genetic relationships between psychotic symptoms. , 2002, The American journal of psychiatry.

[11]  H. Pope,et al.  Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. , 1978, Archives of general psychiatry.

[12]  J. Nurnberger,et al.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. , 1994, Archives of general psychiatry.

[13]  P M Visscher,et al.  Evidence-based psychiatric genetics, AKA the false dichotomy between common and rare variant hypotheses , 2012, Molecular Psychiatry.

[14]  P. Donnelly,et al.  Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype , 2008, Molecular Psychiatry.

[15]  Melissa J. Green,et al.  Schizoaffective disorder: diagnostic issues and future recommendations. , 2008, Bipolar disorders.

[16]  J. Kasanin THE ACUTE SCHIZOAFFECTIVE PSYCHOSES , 1933 .

[17]  Tyrone D. Cannon,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.

[18]  L. Grossman,et al.  Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms , 2000, British Journal of Psychiatry.

[19]  J. Nurnberger,et al.  Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies , 1996, Psychological Medicine.

[20]  M. Owen,et al.  Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to Dsm-5 , 2022 .

[21]  A. Bartsch,et al.  Cycloid psychoses – from clinical concepts to biological foundations , 2002, Journal of Neural Transmission.

[22]  J. Landeira-Fernández,et al.  Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. , 2008, Journal of affective disorders.

[23]  Wolfgang Maier,et al.  Do schizoaffective disorders exist at all? , 2006, Acta psychiatrica Scandinavica.

[24]  K. Kendler,et al.  The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. , 1998, Archives of general psychiatry.

[25]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[26]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[27]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[28]  R. Tandon The nosology of schizophrenia: toward DSM-5 and ICD-11. , 2012, Psychiatric Clinics of North America.

[29]  E. Kraepelin Die erscheinungsformen des Irreseins , 1920 .

[30]  N. Craddock,et al.  Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk , 2009, Molecular Psychiatry.

[31]  S. Strakowski,et al.  Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: comparisons to matched patients with bipolar disorder , 1999, Schizophrenia Research.